NYSE

New York Times Company (The) (NYT)

574 Thanks from members

The New York Times Company (NYSE: NYT) exhibits strong financial health and double-digit revenue growth, yet faces sharp stock correction driven by a slight miss in Q2 digital subscriber additions and conservative forward guidance.

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →